Neo Ivy Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Neo Ivy Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,497	Closed	-$116K	–	688
2021 Q3	$116K	Buy	+3,497	New	+$116K	0.13%	227
2020 Q3	–	Sell	-3,497	Closed	-$116K	–	670
2020 Q2	$116K	Sell	3,497 -6,676	-66%	-$213K	0.13%	227
2020 Q1	$277K	Buy	+10,173	New	+$283K	0.45%	70

Neo Ivy Capital Management's MNTA Position: Q4 2021 in Review

Neo Ivy Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2021, closing a stake of 3,497 shares — an estimated $116K sold.

Neo Ivy Capital Management first reported a position in MNTA in Q1 2020 and held it in 3 quarters. The position peaked at $277K in Q1 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2021.

Neo Ivy Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Neo Ivy Capital Management sold 3,497 Momenta Pharmaceuticals, Inc. shares in Q4 2021, an estimated $116K.
Neo Ivy Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
Neo Ivy Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $277K in Q1 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2021.

Based on Neo Ivy Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.